ONLY FREELITE
 
by Binding Site is referenced in over 3,000 publications, the result of over 18 years of clinical utility.
ONLY FREELITE
 
serum free light chain assays are FDA cleared for both diagnosis and monitoring of Multiple Myeloma and AL Amyloidosis.
ONLY FREELITE
 
on Optilite ensures the best possible performance, delivering results quickly, easily, and accurately.
© Copyright 2019 Binding Site, INC

When Primary Care/Internal Medicine physicians follow Guideline Compliant Testing (SPE + IFE + sFLC), Multiple Myeloma patients can be identified earlier. 

DID YOU KNOW?

To better understand the steps to early diagnosis along with GCT, download your FREE copy of the guidelines.

To better understand the steps to early diagnosis along with GCT, download your FREE copy of the guidelines.

Binding Site, maker of the Freelite® test, is committed to working together with healthcare professionals to improve myeloma patient outcomes through earlier diagnosis.

800-633-4484

DID YOU KNOW?

When Primary Care/Internal Medicine physicians follow Guideline Compliant Testing (SPE + IFE + sFLC), Multiple Myeloma patients can be identified earlier.